Search

everythinglearnresearchcommunity

for

Search:↓

Topical rapamycin may effectively treat fibrous papules on the face.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Aminopterin strongly suppresses epithelial tissues and can treat certain skin conditions but has significant side effects.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Pentoxifylline alone and combined with triamcinolone acetonide is effective for treating localized alopecia areata, with the combination showing the highest effectiveness.

RTA 408 cream protects mice from radiation skin damage.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Platelet-rich plasma doesn't prevent hair loss from chemotherapy, and mononuclear cells only help against hair loss from one specific chemotherapy drug.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Tofacitinib effectively promotes hair regrowth in children with alopecia areata, but more research on long-term safety is needed.

Retinol acetate can reduce the harmful effects of the drug benoxaprofen on white blood cells.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Inhibiting TYK2 can restore hair growth in alopecia areata.

FOL-005, a new substance, was found to reduce hair growth without toxicity when injected into skin, suggesting it could be used to treat excessive hair growth.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Anti-PD-L1 immunotherapy can cause hair loss and unexpected hair color change, but treatment can restore hair growth and color.

A woman with Parkinson's disease experienced hair loss from the Parkinson's medication pramipexole, which improved after stopping the drug.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

An intact skin barrier is crucial to prevent infection in cases of tether-induced tenosynovitis.

Diphenylcyclopropenone treatment helps hair growth in alopecia areata by promoting blood vessel growth and cell survival.

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.